Entscheidungsanalytische Modellierung zur Evaluation der Langzeit-Effektivität und Kosten-Effektivität des Einsatzes der HPV-DNA-Diagnostik im Rahmen der Zervixkarzinomfrüherkennung in Deutschland

Autor: Sroczynski, Gaby, Schnell-Inderst, Petra, Muhlberger, Nikolai, Lang, Katharina, Aidelsburger, Pamela, Wasem, Jurgen, Mittendorf, Thomas, Engel, Jutta, Hillemanns, Peter, Petry, Karl Ulrich, Krämer, Alexander, Siebert, Uwe

Publikováno v: GMS Health Technology Assessment
GMS Health Technology Assessment, Vol 6, p Doc05 (2010)
GMS Health Technology Assessment; VOL: 6; DOC05 /20100427/

Background Persistent infections with high-risk types of human papillomavirus (HPV) are associated with the development of cervical neoplasia. Compared to cytology HPV testing is more sensitive in detecting high-grade cervical cancer precursors, but

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a61ce08b0c1f4cd54617636c3575c88
https://pubmed.ncbi.nlm.nih.gov/21289878

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical

Autor: Mittendorf T, Nocon M, Roll S, Mühlberger N, Sroczynski G, Uwe Siebert, Sn, Willich, Jm, Schulenburg

Publikováno v: Europe PubMed Central
GMS Health Technology Assessment, Vol 3, p Doc08 (2007)
GMS Health Technology Assessment; VOL: 3; DOC08 /20070904/

Introduction The introduction of a screening programme for cervical carcinoma in Germany has led to a significant reduction in incidence of the disease. To date, however, diagnosis in Germany has been based solely on cervical cytology, which has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::44c183cec3507112c62b3bb0b900e60f
http://europepmc.org/abstract/med/21289942